Meng-Hsuan Cheng

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum

Histone Deacetylase

Chemotherapy Induced

Top Venues

Oxidative medicine and cellular longevity

International journal of nanomedicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Peter Wei-Lun Liu, Chia-Yang Li, Wei-Chung Cheng, Chia-Yuan Chang, Yung-Hsiang Chen, Chi-Yu Lu, Shu-Chi Wang, Yu-Ru Liu, Meng-Hsuan Cheng, Inn-Wen Chong, Po-Len Liu
High Mobility Group Box 1 Promotes Lung Cancer Cell Migration and Motility via Regulation of Dynamin-Related Protein 1. International journal of molecular sciences 22 (7) (2021)
Pi-Ling Chou, Ya-Ping Huang, Meng-Hsuan Cheng, Kun-Ming Rau, Yi-Ping Fang
Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis. International journal of nanomedicine 15 (2020)
Meng-Hsuan Cheng, Jun-Yi Weng, Chih-Hung Chuang, Wei-Ting Liao, Yu-Fong Lai, Jia-Yu Liu, Yi-Ping Fang
Prolonging the Half-Life of Histone Deacetylase Inhibitor Belinostat via 50 nm Scale Liposomal Subcutaneous Delivery System for Peripheral T-Cell Lymphoma. Cancers 12 (9) (2020)
Meng-Hsuan Cheng, Hung-Ling Huang, Yen-You Lin, Kuan-Hao Tsui, Pei-Chin Chen, Shu-Yu Cheng, Inn-Wen Chong, Ping-Jyun Sung, Ming-Hong Tai, Zhi-Hong Wen, Nan-Fu Chen, Hsiao-Mei Kuo
BA6 Induces Apoptosis via Stimulation of Reactive Oxygen Species and Inhibition of Oxidative Phosphorylation in Human Lung Cancer Cells. Oxidative medicine and cellular longevity 2019 (2019)